ZEB2 and hepatocellular carcinoma: In this study, we focused on lnc-ZEB2-19 and verified the extreme downregulation of lnc-ZEB2-19 in HCC tissues, which was closely correlated with the MVI-positive rate, advanced stage, and unfavorable outcomes in patients with HCC.